Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew H Briggs

Showing results (11-20 of 114) with videos related to

Pageof 12
Sort By:
Alcohol and Alcoholism (Oxford, Oxfordshire)|December 10, 2009
A systematic review of continuous performance task research in children prenatally exposed to alcoholGayle P Dolan, David H Stone, Andrew H Briggs
Health Economics|May 6, 2004
Regression methods for covariate adjustment and subgroup analysis for non-censored cost-effectiveness dataAndrew R Willan, Andrew H Briggs, Jeffrey S Hoch
International Journal of Chronic Obstructive Pulmonary Disease|May 21, 2008
Pharmacoeconomics in COPD: lessons for the futureHelen J Starkie, Andrew H Briggs, Mike G Chambers
Medical Decision Making : an International Journal of the Society for Medical Decision Making|August 21, 2003
Probabilistic sensitivity analysis for decision trees with multiple branches: use of the Dirichlet distribution in a Bayesian frameworkAndrew H Briggs, A E Ades, Martin J Price
Health Economics|July 12, 2002
Something old, something new, something borrowed, something blue: a framework for the marriage of health econometrics and cost-effectiveness analysisJeffrey S Hoch, Andrew H Briggs, Andrew R Willan
Pharmacoeconomics|June 18, 2005
Development of an economic model to assess the cost effectiveness of treatment interventions for chronic obstructive pulmonary diseaseMichael Spencer, Andrew H Briggs, Ronald F Grossman, et al.
Health Economics|September 24, 2004
Assessing generalisability by location in trial-based cost-effectiveness analysis: the use of multilevel modelsAndrea Manca, Nigel Rice, Mark J Sculpher, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|August 2, 2002
Probabilistic analysis of cost-effectiveness models: choosing between treatment strategies for gastroesophageal reflux diseaseAndrew H Briggs, Ron Goeree, Gord Blackhouse, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2008
Optimal cost-effectiveness decisions: the role of the cost-effectiveness acceptability curve (CEAC), the cost-effectiveness acceptability frontier (CEAF), and the expected value of perfection information (EVPI)Garry R Barton, Andrew H Briggs, Elisabeth A L Fenwick
Medical Decision Making : an International Journal of the Society for Medical Decision Making|October 5, 2016
Estimation of Survival Probabilities for Use in Cost-effectiveness Analyses: A Comparison of a Multi-state Modeling Survival Analysis Approach with Partitioned Survival and Markov Decision-Analytic ModelingClaire Williams, James D Lewsey, Daniel F Mackay, et al.
Pageof 12

Showing results (11-20 of 114) with videos related to

Sort By:
Pageof 12
Alcohol and Alcoholism (Oxford, Oxfordshire)|December 10, 2009
A systematic review of continuous performance task research in children prenatally exposed to alcoholGayle P Dolan, David H Stone, Andrew H Briggs
Health Economics|May 6, 2004
Regression methods for covariate adjustment and subgroup analysis for non-censored cost-effectiveness dataAndrew R Willan, Andrew H Briggs, Jeffrey S Hoch
International Journal of Chronic Obstructive Pulmonary Disease|May 21, 2008
Pharmacoeconomics in COPD: lessons for the futureHelen J Starkie, Andrew H Briggs, Mike G Chambers
Medical Decision Making : an International Journal of the Society for Medical Decision Making|August 21, 2003
Probabilistic sensitivity analysis for decision trees with multiple branches: use of the Dirichlet distribution in a Bayesian frameworkAndrew H Briggs, A E Ades, Martin J Price
Health Economics|July 12, 2002
Something old, something new, something borrowed, something blue: a framework for the marriage of health econometrics and cost-effectiveness analysisJeffrey S Hoch, Andrew H Briggs, Andrew R Willan
Pharmacoeconomics|June 18, 2005
Development of an economic model to assess the cost effectiveness of treatment interventions for chronic obstructive pulmonary diseaseMichael Spencer, Andrew H Briggs, Ronald F Grossman, et al.
Health Economics|September 24, 2004
Assessing generalisability by location in trial-based cost-effectiveness analysis: the use of multilevel modelsAndrea Manca, Nigel Rice, Mark J Sculpher, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|August 2, 2002
Probabilistic analysis of cost-effectiveness models: choosing between treatment strategies for gastroesophageal reflux diseaseAndrew H Briggs, Ron Goeree, Gord Blackhouse, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2008
Optimal cost-effectiveness decisions: the role of the cost-effectiveness acceptability curve (CEAC), the cost-effectiveness acceptability frontier (CEAF), and the expected value of perfection information (EVPI)Garry R Barton, Andrew H Briggs, Elisabeth A L Fenwick
Medical Decision Making : an International Journal of the Society for Medical Decision Making|October 5, 2016
Estimation of Survival Probabilities for Use in Cost-effectiveness Analyses: A Comparison of a Multi-state Modeling Survival Analysis Approach with Partitioned Survival and Markov Decision-Analytic ModelingClaire Williams, James D Lewsey, Daniel F Mackay, et al.
Pageof 12